Overview
Total raised
$63M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 12, 2017 | E-Scape Bio Closes $63M Series A Extension | SAN FRANCISCO, CA, Biopharmaceutical company developing therapies to treat neurodegenerative diseases, today announced it has closed an extension of its Series A financing. >> Click here for more funding data on E-Scape Bio >&g... |
| Jul 12, 2017 | E-Scape Bio Raises $63m in Series Funding | E-Scape Bio, a San Francisco, CA-based biopharmaceutical company developing therapies to treat neurodegenerative diseases, closed an extension of its Series A financing bringing the total amount raised in the round to $63m. New investors in... |
| Jul 12, 2017 | Big Pharma-backed E-Scape Bio hits $63M in extended series A | California neurodegenerative disease upstart E-Scape Bio has closed an extension of its series A round, boosting its cash to $63 million. The biotech can boast of some big backers, including VC OrbiMed, Novo Holding, Johnson & Johnson I... |
Reviews 0
FAQ about E-Scape Bio
How much funding has E-Scape Bio raised?
E-Scape Bio has raised $63M in total across 1 funding round.
What has the press written about E-Scape Bio?
Parsers VC has collected 4 articles mentioning E-Scape Bio, among them “E-Scape Bio Closes $63M Series A Extension” (Jul 12, 2017) and “E-Scape Bio Raises $63m in Series Funding” (Jul 12, 2017).
Is E-Scape Bio still active?
Yes, E-Scape Bio is active; its latest activity on Parsers VC dates from Jul 12, 2017.